Gene expression signatures in blood could predict the onset of tuberculosis (TB) at a very early stage before symptoms arise, reveals a new study.
Gene expression signatures in blood could now be used to predict the tuberculosis onset three to six months prior people become unwell, reports a new study. The findings of the study are published in the journal Lancet Respiratory Medicine.// Gene expression signatures are single or combined measurements of levels of specific gene products and are being tested in a range of diseases to aid diagnosis, prognosis, or prediction of the response to treatment. Some are already being used to support the management of cancers, but none have reached the clinic in infectious diseases, such as tuberculosis (TB).
‘Tuberculosis is a disease caused by bacteria (Mycobacterium tuberculosis) that most often affects the lungs.
’
For this study, researchers initially conducted a systematic review of published gene signatures found to be present in blood samples from people with TB, compared to healthy individuals. From this, 17 candidate gene expression signatures for TB were identified and tested in more than 1,100 blood samples in published data sets from South Africa, Ethiopia, The Gambia, and the UK.
Scientists analyzed samples from people who had no TB symptoms at the time they gave blood. Those people were then followed up to identify which participants developed TB in the subsequent months.
Researchers found that eight of these signatures, including measurement of expression of a single gene, could predict the diagnosis of TB within three to six months, which falls within the accuracy required by the World Health Organisation (WHO) for new diagnostic tests*. This accuracy was achieved, by revealing the patients' immune responses to bacteria before the symptoms of the disease develop.
Lead author Dr. Rishi Gupta (UCL Institute for Global Health) said: "The emergence of gene expression signature tests, which can aid diagnosis and early treatment, provides real hope for the management of infectious diseases. In this study we identify multiple signatures to identify the onset of tuberculosis, which is extremely encouraging, potentially providing multiple targets for early detection.
Advertisement
TB is spread from person to person through the air. When people with lung TB cough, sneeze, or spit, they propel the TB germs into the air. Another person needs to inhale only a few of these germs to become infected. Worldwide, TB is one of the top 10 causes of death and in 2018 1.5 million people died from the disease.
Advertisement
"However, we currently do not know which people are most likely to develop TB disease after being infected. If we can identify these individuals, we can treat their infection more easily and prevent it from spreading to others.
"Our findings establish the gene signatures in the blood, which show the most promise for identifying people who are at risk of disease. Future development of a blood test based on these findings could make an important contribution to efforts to reduce the impact and spread of this deadly infection."
Source-Eurekalert